Plasmodium falciparum malaria is a severe manifestation of malaria caused by infection with the Plasmodium falciparum parasite. This species is recognized for its capacity to cause life-threatening disease, distinguished from other malaria species by its clinical severity and specific parasitic characteristics. The condition is formally categorized as a parasitic infectious disease with dedicated coding in international classification systems.
Disease Profile
ParasiticPlasmodium falciparum malaria
恶性疟
Plasmodium falciparum malaria is a severe form of malaria caused by the Plasmodium falciparum parasite, representing one of the most dangerous malaria species affecting humans. The disease is characterized by irregular recurrence of fever paroxysms and prolonged or continuous fever episodes. First-line treatment frequently employs the artemether-lumefantrine combination, with lumefantrine's longer half-life helping to clear residual parasites. The disease is classified under ICD-10 code B50 and ICD-11 code 1F40 within the parasitic disease category.
The clinical presentation of Plasmodium falciparum malaria is marked by irregular recurrence of fever paroxysms, a hallmark pattern distinguishing this form of malaria. Patients may experience prolonged or continuous fever rather than the predictable periodic fever seen with other malaria species. The severity of clinical course distinguishes Plasmodium falciparum from other malaria types, with potential for rapid deterioration if untreated.
Source-backed detail regarding the geographic distribution, outbreak patterns, and global burden of Plasmodium falciparum malaria is not yet available from the provided sources. Similarly, information on reservoir hosts, ecological exposure settings, and population-level surveillance metrics cannot be substantiated from the current evidence base.
Source-backed detail regarding the transmission routes, vector species, or exposure mechanisms for Plasmodium falciparum malaria is not yet available from the provided sources. The vector biology and transmission ecology require additional source documentation for surveillance purposes.
Source-backed detail regarding specific high-risk populations for Plasmodium falciparum malaria, including demographic risk factors, immunocompromised status, pregnancy-related vulnerability, or geographic risk stratification, is not yet available from the provided sources.
Source-backed detail regarding public health prevention measures, exposure control strategies, or vector control interventions for Plasmodium falciparum malaria is not yet available from the provided sources. Prevention guidance would require supplementary evidence sources beyond the current documentation.
Plasmodium falciparum malaria is coded as B50 under ICD-10 and 1F40 under ICD-11 classification systems, facilitating standardized disease surveillance and reporting. The distinction of this as a severe malaria form has implications for monitoring case severity distributions and treatment outcomes. Surveillance systems should note that the artemether-lumefantrine combination represents first-line therapy, which may influence treatment success metrics and drug resistance monitoring efforts.
- B50
- 1F40
Dataset Archive
Supplementary Data | Multi-country disease dataset
Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.
Suggested presentation pattern: cite the data version and coverage window when exporting charts or tables for publication.